Design Therapeutics (DSGN) logo

DSGN earnings date, and what happened the last 4 times

Next report

Thu Nov 5

Quality Score today -3

Before the open, in 10 days. Expected: the company has not confirmed it.

DSGN closed higher after 3 of its last 4 reports. On average it closed +7.3% the session after a report.

The moment DSGN reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when DSGN reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after DSGN's last 4 reports

DSGN's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 3, 20262026 · Before open2estimated-1.1%+4.8%
Apr 28, 20262026 · After close10estimated+1.5%+23.3%
Mar 9, 20262026 · After close10estimated+1.6%-3.7%
Nov 5, 20252025 · After close7estimated-1.7%+4.9%
  • Aug 3, 2026, before the open: that session DSGN opened -1.1% and closed +4.8%, and five sessions on it stood +14.9%. Its Quality Score going in was 2 (Below Average), estimated.
  • Apr 28, 2026, after the close: the next session DSGN opened +1.5% and closed +23.3%, and five sessions on it stood +4.7%. Its Quality Score going in was 10 (Average), estimated.
  • Mar 9, 2026, after the close: the next session DSGN opened +1.6% and closed -3.7%, and five sessions on it stood +6.0%. Its Quality Score going in was 10 (Average), estimated.
  • Nov 5, 2025, after the close: the next session DSGN opened -1.7% and closed +4.9%, and five sessions on it stood +16.2%. Its Quality Score going in was 7 (Average), estimated.

Across these 4 reports DSGN opened higher after 2 of 4 and closed higher after 3 of 4; on average it opened +0.1%, closed +7.3%, and stood +10.4% five sessions on. Its Quality Score is -3 today, against 2 going into its Aug 3, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +23.3% after the Apr 28, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see DSGN's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about DSGN's earnings

As of Oct 26, 2026: Design Therapeutics (DSGN): expected to report Thu Nov 5, before the open. DSGN closed higher after 3 of its last 4 reports. Its Quality Score is -3 (Poor). Scores as of 10:16 PM ET, 15 minutes behind.

When is DSGN's next earnings date?

Expected to report Thu Nov 5, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. DSGN closed higher after 3 of its last 4 reports. Past behavior, not a forecast.

Does DSGN report before or after the market?

DSGN is expected to report Thu Nov 5, before the open. Its last 4 reports came 3 after the close and 1 before the open.

How did DSGN stock react to its last earnings report?

Aug 3, 2026, before the open: that session DSGN opened -1.1% and closed +4.8%, and five sessions on it stood +14.9%.

Does DSGN stock usually go up after earnings?

DSGN closed higher after 3 of its last 4 reports. On average it closed +7.3% the session after a report, after opening +0.1%. Past behavior, not a forecast.

Design Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.